The challenge of checkpoint inhibitors in prostate cancer: Drugs for the many but useful to a few Editorial


Author: Slovin, S. F.
Title: The challenge of checkpoint inhibitors in prostate cancer: Drugs for the many but useful to a few
Keywords: unclassified drug; review; drug efficacy; antineoplastic agent; cancer immunotherapy; ddr; prostate cancer; immunotherapy; sipuleucel t; human; priority journal; checkpoint inhibitor; pembrolizumab; checkpoint inhibitors; solid malignant neoplasm; immune desert
Journal Title: Immunotherapy
Volume: 12
Issue: 4
ISSN: 1750-743X
Publisher: Future Medicine  
Date Published: 2020-03-01
Start Page: 219
End Page: 221
Language: English
DOI: 10.2217/imt-2019-0221
PUBMED: 32172641
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 1 May 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Susan Slovin
    254 Slovin